DEVELOPMENT OF BIGELS CONTAINING ANTIFUNGAL AGENT FOR VAGINAL INFECTION

Authors

DOI:

https://doi.org/10.22159/ijpps.2022v14i10.45134

Keywords:

Hydrogel, HPMC, Organogel, Vagina, Vaginal infections, Surfactant

Abstract

Objective: Bigels are unique semi-solid preparations that have piqued the focus of numerous scientists owing to their significant advantages over ordinary gels. The purpose of this study was to develop and characterize innovative Bigels for applications in drug delivery by combining Hydroxypropyl methylcellulose hydrogel and sorbitan monostearate, oils like coconut and olive-based organogel. The existence of both aqueous and oil phases as bigel was revealed by microscopy.

Methods: Hydrogels and organogels were prepared separately, and bigels were formed by combining hydrogel and organogel in a predetermined ratio. They were then analyzed employing various physicochemical tests i. e in vitro drug release, microscopy, and other techniques. Microscopy, viscosity measurement, mechanical analysis, and differential scanning calorimetry were used to examine the bigel's microstructures and physicochemical properties.

Results: Tube inversion tests reveal that the bigel doesn’t flow under its own weight till 167 min. The microscopy suggested that the gels exhibited fiber-like structures due to the trapping of the organogel inside hydrogel molecules; this entrapment was demonstrated to be uniformly accomplished, resulting in formulation stability, and the DSC study reveals that the terbinafine is not decomposed also after formulating in bigel, and the terbinafine bigel was also found to be stable. The drug-loaded gels demonstrated effective antibacterial activity against Candida species. The formulated bigel shows initial release in 2 h and slowly release later in 4 h. The formed bigel is found to be stable after 3 mo with a pH range of 7.07±0.04, showing good spreadability and drug content was 99.99±0.75.

Conclusion: Terbinafine, the drug of preference for the treatment of bacterial vaginosis, demonstrated diffusion-mediated drug release when placed into bigels. In general, the produced bigels might be employed as delivery vehicles for drugs delivered vaginally.

Downloads

Download data is not yet available.

References

Mercer, B.M., Miodovnik, M. Thurnau, G.R, et al. The preterm prediction study: Significance of vaginal infections. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am. J. Obs. Gynecol. 1995;173:1231-1235.

Coggins C et al. Women’s preferences regarding the formulation of over-the-counter vaginal spermicides. AIDS. 1998;12:1389-1391.

Sexually transmitted diseases treatment guideline. Centers for Disease Control and Prevention. MMWR Recomm Rep. 2002;51(RR-6):1-80.

Weinstein L, Henzel MR, Tsina. IW vaginal retention of 2% butoconazole nitrate cream: comparison of a standard and sustained-release preparation. Clin Ther. 1994;16(6):930-934.

Singh H, Sharma R, Joshi M, et al. Transmucosal delivery of Docetaxel by mucoadhesive polymeric nanofibers. Artif Cells Nanomed Biotechnology. 2014;43(4):263-269.

A. Shakeel, U. Farooq, T. Iqbal, S. Yasin, F.R. Lupi, D. Gabriele. Key characteristics and modelling of bigels systems: a review. Mater Sci Eng C. 2019;97:932–953.

G. Haering, P.L. Luisi. Hydrocarbon gels from water-in-oil microemulsions. The Journal of Physical Chemistry. 1986;116(24):5892-5895.

Khan AW, Kotta S, Ansari SH, Sharma RK, Kumar A. Formulation, development, optimization, and evaluation of aloe vera gel for wound healing. Pharmacogn Mag. 2013;9(1): 6-10.

Martins, A. J., Cerqueira, M. A., Cunha, R. L., & Vicente, A. A. Fortified beeswax oleogels: Effect of β-carotene on the gel structure and oxidative stability. Food and Function. 2017;7(11):3781-4232.

V.K. Singh, K. Pal, D.K. Pradhan, K. Pramanik. Journal of Applied Polymer Science. 2013;130:1503-1515.

Vinay K. Singh, Arfat Anis, Indranil Banerjee, Krishna Pramanik, Mrinal K. Bhattacharya, Kunal Pal. Preparation and characterization of novel carbopol-based bigels for topical delivery of metronidazole for the treatment of bacterial vaginosis. Materials Science & Engineering. 2014;C44:151–158.

Ilomuanya MO, Hameedat AT, Akang EN, Ekama SO, Silva BO, Akanmu AS. Development and evaluation of mucoadhesive bigel containing tenofovir and maraviroc for HIV prophylaxis. Futur J Pharm Sci. 2020;6(1):1-12.

Published

01-10-2022

How to Cite

RAYTTHATHA, N., and J. VYAS. “DEVELOPMENT OF BIGELS CONTAINING ANTIFUNGAL AGENT FOR VAGINAL INFECTION”. International Journal of Pharmacy and Pharmaceutical Sciences, vol. 14, no. 10, Oct. 2022, pp. 38-42, doi:10.22159/ijpps.2022v14i10.45134.

Issue

Section

Original Article(s)